Metraipolis › archive › dc_78b3247fd91e

An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in… — Europe PMC PMID:41321117

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41321117
DOI
10.1093/cid/ciaf646
License (as archived)
solo-consultazione
Archived
2026-11-06T09:27:55.980Z
SHA-256 of the archived text
453f51ce35f8ea34aa9791efd1bb80518542b1e194fc66e83619d0780688133b
Stable URL of this page
https://metraipolis.com/documento/dc_78b3247fd91e

How to cite

An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in… — Europe PMC PMID:41321117 — Europe PMC (en), https://europepmc.org/article/MED/41321117 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_78b3247fd91e (Metraipolis archive dc_78b3247fd91e, sha256 453f51ce35f8ea34aa9791efd1bb80518542b1e194fc66e83619d0780688133b)
BibTeX
@misc{dc78b3247fd91e,
  title = {An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in… — Europe PMC PMID:41321117},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41321117},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_78b3247fd91e; sha256 453f51ce35f8ea34aa9791efd1bb80518542b1e194fc66e83619d0780688133b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41321117. Agents can read the archived copy with the MCP tool read_document.